Posts by Edwin Choy, MD, PhD
-
Advancing Novel Therapeutic Approaches to Treat Rare Forms of Sarcoma
Massachusetts General Hospital participates in a clinical trial that accelerated the approval of a T cell receptor therapy targeting advanced sarcomas.
Biography
Edwin Choy, MD, PhD, is the Director of Sarcoma Research at the Division of Hematology Oncology at Massachusetts General Hospital. He specialized in the medical management of patients with sarcomas, gastrointestinal stromal tumors, chordomas, and desmoid tumors. He works closely with a team of world class surgical, orthopedic, and radiation oncologists as well as connective tissue pathologists and radiologists to provide optimal care for his patients. Dr. Choy directs a clinical trials program at the MGH Center for Sarcoma and Connective Tissue Oncology that includes 9-12 active phase I-III clinical trials. He also maintains an active scientific research program that investigates diverse areas of sarcoma therapy ranging from the use of nanotechnology and other translational research tools aimed at developing new targeted therapies for treating cancers to preclinical studies using cell lines and animal models to better understand the molecular basis of sarcoma biology.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
